Skip to content

Drug interactions

Ciltacabtagene autoleucel + Tacrolimus

Severity: Major

Ciltacabtagene autoleucel and Tacrolimus: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Tacrolimus is a calcineurin inhibitor that suppresses T-cell activation and may blunt the expansion and activity of CAR-T cells. This could reduce the antitumor effect and also adds to infection risk.

What this interaction means in plain words

Ciltacabtagene autoleucel and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ciltacabtagene autoleucel belongs to Miscellaneous; Tacrolimus belongs to Miscellaneous.

Evidence level: Low

Why it happens

Calcineurin inhibition suppresses T-cell activation and proliferation, which may impair CAR-T cell function.

What to do

Avoid immunosuppressants such as tacrolimus around the time of CAR-T infusion unless needed to treat toxicity or transplant rejection. If it is required, involve the treating hematology team and monitor for infection and loss of response.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ciltacabtagene autoleucel and Tacrolimus, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ciltacabtagene autoleucel with Tacrolimus?

MediHelp rates the interaction as major. Ciltacabtagene autoleucel and Tacrolimus can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Tacrolimus is a calcineurin inhibitor that suppresses T-cell activation and may blunt the expansion and activity of CAR-T cells. This could reduce the antitumor effect and also adds to infection risk.

How serious is the interaction between Ciltacabtagene autoleucel and Tacrolimus?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid immunosuppressants such as tacrolimus around the time of CAR-T infusion unless needed to treat toxicity or transplant rejection. If it is required, involve the treating hematology team and monitor for infection and loss of response.

What other medicines interact with Tacrolimus?

MediHelp also lists interactions of Tacrolimus with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Cidofovir. The full list is on the Tacrolimus page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in